Navigation Links
Blue Light Destroys Antibiotic-Resistant Staph Infection - Results Reported in Photomedicine and Laser Surgery Journal
Date:1/29/2009

NEW ROCHELLE, N.Y., Jan. 29 /PRNewswire/ -- Two common strains of methicillin-resistant Staphylococcus aureus, commonly known as MRSA, were virtually eradicated in the laboratory by exposing them to a wavelength of blue light, in a process called photo-irradiation that is described in a paper published online ahead of print in Photomedicine and Laser Surgery. The article will appear in the April 2009 issue (Volume 27, Number 2) of the peer-reviewed journal published by Mary Ann Liebert, Inc. The paper is available free online at www.liebertpub.com/pho

Antibiotic-resistant bacterial infections represent an important and increasing public health threat. At present, fewer than 5% of staphylococcal strains are susceptible to penicillin, while approximately 40%-50% of Staph aureus isolated have developed resistance to newer semisynthetic antibiotics such as methicillin as well.

Chukuka S. Enwemeka, Deborah Williams, Sombiri K. Enwemeka, Steve Hollosi, and David Yens from the New York Institute of Technology (Old Westbury, NY) had previously demonstrated that photo-irradiation using 405-nm light destroys MRSA strains grown in culture. In the current study, "Blue 470-nm Light Kills Methicillin-Resistant Staphylococcus aureus (MRSA) in Vitro," the authors exposed bacterial colonies of MRSA to various doses of 470-nm light, which emits no UV radiation.

The two MRSA populations studied--the US-300 strain of CA-MRSA and the IS-853 strain of HA-MRSA--represent prominent community-acquired and hospital-acquired strains, respectively.

The authors report that the higher the dose of 470-nm blue light, the more bacteria were killed. High-dose photo-irradiation was able to destroy 90.4% of the US-300 colonies and the IS-853 colonies. The effectiveness of blue light in vitro'/>"/>

SOURCE Mary Ann Liebert, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Uroplasty Highlights Results From Clinical Study on Macroplastique(R) for the Treatment of Stress Urinary Incontinence
2. New Keppra XR(TM) Data Highlight Its Role for Patients with Partial-Onset Seizures
3. Research Highlights New Approaches to Prevent Blood Clots in Several High-Risk Patient Populations Including Largest Study Ever to Examine Use of Blood-Thinning Medication in Patients With Cancer
4. Late-Breaking Data Highlighting Research Advances in Several Blood Disorders to Be Presented At the American Society of Hematology Annual Meeting
5. Light Sciences Oncology Completes Patient Enrollment in Phase 3 Clinical Trial of Litx as a Treatment for Hepatocellular Carcinoma
6. Schering-Plough Highlights R&D Pipeline Progress, Innovation and Breadth of Research Projects
7. Opportunities to Highlight Type 1 Diabetes in November
8. Trius Antibiotics to be Highlighted in 18 Presentations at ICAAC/IDSA
9. Battelle Scientists Named on Patent for Making Oxygen From Light and Water
10. New Studies Highlight Benefits of Coblation(R)-Assisted Procedures in Airway Fire Prevention and Endoscopic Sinus Surgery
11. Symposium Highlights Yale Study Indicating Role of AHCC(R) for Immune System Enhancement and as a Promising Cancer Preventative

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)... , CHICAGO and STAFA, Switzerland, Nov. 25 /...eading manufacturer of innovative hearing solution...e for Adults Conference, focusing on the special n...ht together leading experts in aging and audiology...s who work everyday with older people with hearing...
(Date:11/25/2009)... , BRIDGEWATER, N.J., Nov. 25 ...E® (etravirine) tablets, a non-nucleoside rev... the only NNRTI specifically indicated for use in ...virologic failure with HIV-1 strains resistant to ...he traditional approval is based on 48-week data f...
(Date:11/25/2009)... , COLLEGE PARK, Md., Nov. 25 /PRNewswire-...ny developing a shaving cream-like foam that stops...he Most Promising Security Idea category of the Gl...nounce today. ,, Selected from more than 100 en...ed their invention at the GSC Security Summit conf...
Breaking Medicine Technology:Phonak Successfully Hosts Hearing Care for Adults 2009 Conference 2Phonak Successfully Hosts Hearing Care for Adults 2009 Conference 3U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 2U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 3U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 4U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 5Remedium Technologies Wins Most Promising Security Idea at Global Security Challenge 2009 with Blood-Clotting Foam 2Remedium Technologies Wins Most Promising Security Idea at Global Security Challenge 2009 with Blood-Clotting Foam 3All Nursing Schools Discusses Obama 26apos 3Bs Health Care Reform and Nursing Career Opportunities 52347 1All Nursing Schools Discusses Obama 26apos 3Bs Health Care Reform and Nursing Career Opportunities 52347 2All Nursing Schools Discusses Obama 26apos 3Bs Health Care Reform and Nursing Career Opportunities 52347 3Jackson Tragedy May Serve to Educate Public on Addiction Says American Society of Addiction Medicine 52343 1Jackson Tragedy May Serve to Educate Public on Addiction Says American Society of Addiction Medicine 52343 2Jackson Tragedy May Serve to Educate Public on Addiction Says American Society of Addiction Medicine 52343 3Jackson Tragedy May Serve to Educate Public on Addiction Says American Society of Addiction Medicine 52343 4Kansas City Patients Rate Their Doctors in Most Reliable Survey of Its Kind 52339 1Kansas City Patients Rate Their Doctors in Most Reliable Survey of Its Kind 52339 2Kansas City Patients Rate Their Doctors in Most Reliable Survey of Its Kind 52339 3Kansas City Patients Rate Their Doctors in Most Reliable Survey of Its Kind 52339 4Kansas City Patients Rate Their Doctors in Most Reliable Survey of Its Kind 52339 5
...ults presented at the 43rd European Association fo...ual Meeting, AMSTERDAM, The Netherlands, Sept. 19...ng of the European Association for the Study,of Di...tazone HCl) to,reduce the risk of ischemic cardiov...ACTOS is an oral antidiabetic agent for type 2 dia...
...HINGTON, Sept. 18 A long-term study found,that a ...h life-threatening,diseases, such as leukemia and ... activity for recipients. Further, males are likel...he sexuality of female patients,remains compromise...cancer,survivors regained levels of sexual activit...
Other Medicine Technology:ACTOS(R) (pioglitazone HCl) Demonstrates Reduced Risk of Ischemic Cardiovascular Disease in Patients with Type 2 Diabetes 2ACTOS(R) (pioglitazone HCl) Demonstrates Reduced Risk of Ischemic Cardiovascular Disease in Patients with Type 2 Diabetes 3Sexual Function Affected by Stem Cell Transplant According to Long-Term Study 2Sexual Function Affected by Stem Cell Transplant According to Long-Term Study 3Sexual Function Affected by Stem Cell Transplant According to Long-Term Study 4
(Date:11/27/2009)...Newswire-FirstCall/ -- The Gymboree Corporation (N...OO, will present at the NASDAQ OMX 23rd Investor P...n London, England, on Wednesday, December 2, 2009,...dcast of The Gymboree Corporation,s presentation o...m, click on "Our Company" at the bottom of the pag...
(Date:11/27/2009)...ldings has announced that it has become a national...argest nonprofit organizations dedicated to arthri... Delray Beach, FL (Vocus) Novemb...O), a company specializing in the marketing and re... has announced today that is has become a national...
(Date:11/27/2009)...th™ announced today that Spectrum Health (Gr...nterprise orthopedic templating solution and its T... (PRWEB) November 27, 2009 -- Voyant He...Grand Rapids, Michigan) has licensed its TraumaCad... TraumaCad Extend workflow solution, to allow its ...
(Date:11/26/2009)...wire/ -- With cold and flu season upon us, it,s mo... control the spread of infections and avoid illnes... ourselves healthy, but to avoid transmitting illn...IC (certified in infection-control), nursing direc...at Hospital for Special Surgery (HSS) in Manhattan...
(Date:11/26/2009)...an lead to strains or worse , , THURSDAY... wrong with stuffing your turkey full to bursting,...your suitcase as you pack for holiday trips. , ...S. hospital emergency rooms, doctors, offices, cli...ted injuries, such as muscle strains, pulls and te...
Breaking Medicine News(10 mins):Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 2Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 3Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 4Health News:Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 2Health News:Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 3Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 2Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 3Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 4Health News:Pack Right for the Holidays to Avoid the ER 2
...onference Call Pro Forma Combined Third Quar...ov. 4 Thermage, Inc.,(Nasdaq: THRM ) today provi...d September 30, 2008 for both Thermage and Reliant... regarding the merger,of the two companies prior t...
...ity to Work Together to Improve Global, Sanitati...iseases That Endanger Million...- The eighth annual World Toilet,Summit and Expo w...cretary-General,s Advisory Board on Water and,Sani...
...corporated Extols Virtues of Hosting In-Office Wel... CN (PRWEB) November 4, 2008 -- Vertrue Incorpora...y, thinks there,s a lot to be said for keeping emp...cal health can get a quick boost from a well-run h...
...dical Lasers,Limited (ASX:ELX), a global leader in...d ultrasound systems, today announced that it will..., Integre Pro(TM), at the,upcoming American Academ...ulti-color photocoagulation. The combination of tw...
...f HPV (human papillomavirus) vaccines and the vali...sed oral cancers are reported in two studies by a ... Leading HPV expert Maura Gillison, M.D., Ph.D., ...r these cancers, reports her latest work in the No...
...., Nov. 3 Psychemedics Corporation,(Nasdaq: PMD ...for the,period ended September 30, 2008. The Compa...r share payable to shareholders of record as of,De...was $6.2 million, down 4% as,compared to $6.5 mill...
Other Medicine News:Health News:Thermage Discloses Preliminary 3Q 2008 Results for Thermage and Reliant 2Health News:Thermage Discloses Preliminary 3Q 2008 Results for Thermage and Reliant 3Health News:Thermage Discloses Preliminary 3Q 2008 Results for Thermage and Reliant 4Health News:World Toilet Summit Opens in Macau 2Health News:World Toilet Summit Opens in Macau 3Health News:Vertrue Incorporated Gives Tips on How to Hold a Health Fair 2Health News:Vertrue Incorporated Gives Tips on How to Hold a Health Fair 3Health News:Ellex to Preview New Multi-Color Photocoagulation Laser at AAO 2Health News:Research indicates need for effective HPV vaccine for women and men and a simple HPV screening test 2Health News:Research indicates need for effective HPV vaccine for women and men and a simple HPV screening test 3Health News:Psychemedics Corporation Announces Third Quarter Results 2Health News:Psychemedics Corporation Announces Third Quarter Results 3Health News:Psychemedics Corporation Announces Third Quarter Results 4Health News:Psychemedics Corporation Announces Third Quarter Results 5
...rs is available, ensuring the customers to find th...fic requirements. miniTHERM incubators have a capa... saving. Their size corresponds approximately to a...p to three units on top of each other. The units h...
IR Autoflow Dual Chamber Over-Under Water-Jacketed CO2 Inc.
SB Medium
Tryptic Soy Broth
Medicine Products: